Crinetics Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Crinetics Pharmaceuticals, Inc. (CRNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-09-30 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-06-30 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-02-26 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-12 | 0.00% 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-08 | 0.00% 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00% 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-12 | 0.00% 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-08 | 0.00% 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 0.00% 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 0.00% 10-K · filed 2022-03-30 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-05 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-10 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 0.00% 10-K · filed 2021-03-30 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | 0.00% 10-K · filed 2020-03-09 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-13 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-30 |